Dr. Joseph Scalea

Dr. Daniel Judge is a professor of medicine in cardiology at MUSC. He received his medical degree at the University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology, and advanced heart failure/transplant cardiology at Johns Hopkins. He is board-certified in both cardiology and advanced heart failure/transplant cardiology.Dr. Judge takes care of adult patients with inherited forms of cardiovascular disease, as well as congestive heart failure. As director of the cardiovascular genetics program, Dr. Judge has extensive experience caring for individuals and families with inherited forms of cardiomyopathy, aortic aneurysm, amyloidosis, and cardiac involvement from other genetic conditions.He has authored more than 150 scientific manuscripts. Dr. Judge is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation. Dr. Judge is currently accepting new patients.

Dr. Zile is a graduate of Rush University School of Medicine. He did his internal medicine residency at Rush Presbyterian St. Lukes Medical Center in Chicago, a clinical cardiology fellowship at Tufts-New England Medical Center in Boston and a research cardiology fellowship at the Department of Veterans Affairs Medical Center, Boston. Dr. Zile is currently the Charles Ezra Daniel professor of medicine at the Medical University of South Carolina.He also serves as the director of cardiology at the Ralph H. Johnson Department of Veteran's Affairs Medical Center in Charleston. He is an adjunct professor of bioengineering at Clemson University.Dr. Zile's research career has involved both basic laboratory research examining the mechanisms of disease development and progression and translational clinical research examining the application of these basic mechanisms to development of effective treatment methods.Dr. Zile is a recognized leader in the areas of cardiac function, congestive heart failure, diastolic heart failure and valvular heart disease. His research is supported by grants from the National Heart, Lung and Blood Institute, the American Heart Association, the Department of Veterans Affairs and the Medical University of South Carolina.Dr. Zile is the author of over 100 peer-reviewed publications. He is a member of a number of professional societies including the American College of Physicians, American Federation of Clinical Research, American Heart Association, American College of Cardiology, the Heart Failure Society of America, International Society of Heart Failure, and the American Physiology Society. Dr. Zile has served on the research, educational and program committees of these organizations. He serves on the editorial boards of the Journal of the American College of Cardiology and Circulation and is an editorial consultant to a number of others including Circulation Research, Journal of Clinical Investigation and the American Journal of Physiology. Dr. Zile is a member of the Association of University Cardiologists and a member of the ABIM Subspecialty Board on Cardiovascular Disease. Dr. Zile is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Hypertensive Heart Disease, Pacemaker Implantation, and Cardiac Ablation. Dr. Zile is currently accepting new patients.

Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Heart Failure, Heart Transplant, and Cardiac Ablation. Dr. Tedford is currently accepting new patients.